Health
Glucosidase inhibitors are promising as new therapeutic agents for SARS-CoV-2 – Eminetra
In a new study posted on bioRxiv* Preprint server, US researchers found that two iminosugar glucosidase inhibitors suppress the replication of severe acute respiratory…
In a new study posted on bioRxiv* Preprint server, US researchers found that two iminosugar glucosidase inhibitors suppress the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in tissue culture at least one-hundredth of the required concentration. It reports that it has the ability to do so because of its cytotoxic effects.
As the pandemic of coronavirus disease 2019 (COVID-19) progresses, there is an urgent need for new antiviral agents that are effective against SARS-CoV-2,…
-
Noosa News24 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News22 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News23 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
General20 hours agoDairy farmers devastated by floods across parts of New South Wales